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Abstract
Innate lymphoid cells (ILCs) regulate stromal, epithelial and immune cells, but their impact on B 
cells remains unclear. We identified RORγt+ ILCs nearby the marginal zone (MZ), a splenic 
compartment containing innate-like B cells that respond to circulating T cell-independent (TI) 
antigens. Spenic ILCs established a bidirectional crosstalk with MAdCAM-1+ marginal reticular 
cells by providing tumor necrosis factor (TNF) and lymphotoxin, and activated MZ B cells via 
BAFF, CD40 ligand and the Notch ligand, Delta-like 1. Splenic ILCs further helped MZ B cells 
and their plasma cell progeny by co-opting neutrophils through the release of GM-CSF. 
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Consequently, ILC depletion impaired both pre- and post-immune TI antibody responses. Thus, 
ILCs integrate stromal and myeloid signals to orchestrate innate-like antibody production at the 
interface between the immune and circulatory systems.
INTRODUCTION
The spleen is a highly perfused organ specialized in host defense against blood-borne 
pathogens. Interposed between the follicles of the splenic white pulp and the circulation, the 
marginal zone (MZ) contains B cells enmeshed with macrophages and dendritic cells (DCs) 
in a stromal reticular cell network1-3. All of these cells provide an efficient 
immunosurveillance of the circulatory system by readily interacting with circulating 
antigens from commensal or pathogenic microbes owing to the slow flow rate of the blood 
passing through the MZ4. Following antigen capture, macrophages, DCs and possibly 
neutrophils of the innate immune system expose antigen to MZ B cells, a unique subset of 
antibody-producing lymphocytes that develop from transitional B cells in response to 
NOTCH2 signals5.
Lymphoid sites positioned between the host and the environment contain innate-like B and 
T cells that belong to the adaptive immune system, but share several properties with effector 
cells of the innate immune system. Mucosal and serosal membranes include innate-like B-1 
cells that generate a first line of protection through early production of low-affinity 
immunoglobulin M (IgM) to bacteria6. When microbes breach the mucosal barrier and enter 
the general circulation, innate-like MZ B cells provide a second line of protection via low-
affinity IgM and IgG that bridge the temporal gap required for the slower production of 
high-affinity IgG by follicular (FO) B cells4.
Similar to B-1 cells, MZ B cells express clonally distributed and somatically recombined but 
rather unspecific B cell receptor (BCR) molecules encoded by poorly diversified 
immunoglobulin (Ig) genes4, 6. MZ B cells also express non-clonally distributed and 
germline-encoded Toll-like receptors (TLRs)7, a subfamily of nonspecific microbial sensors 
generally known as pattern recognition receptors. Typically expressed by effector cells of 
the innate immune system, TLRs activate MZ B cells after recognizing conserved microbial 
molecular signatures in cooperation with BCRs8. The activation of MZ B cells is further 
enhanced by B cell-stimulating cytokines released by DCs, macrophages and 
neutrophils9, 10.
Besides innate-like lymphocytes, mucosal surfaces include innate lymphoid cells (ILCs) that 
express neither somatically recombined antigen receptors nor conventional surface lineage 
molecules11. These ILCs require the transcriptional repressor inhibitor of DNA 2 (Id2) and 
the cytokine interleukin-7 (IL-7) for their development and generate cytokine secretion 
patterns that mirror those of T helper (TH) cells of the adaptive immune system12, 13. Similar 
to pro-inflammatory TH1 cells, group 1 ILCs (ILC1) release interferon-γ (IFN-γ) and require 
the transcription factor T-bet for their development as do natural killer (NK) cells of the 
innate immune system14. ILC2, which include natural helper cells and nuocytes, secrete 
IL-5 and IL-13 and require the transcription factor GATA-3, thus resembling pro-
inflammatory TH2 cells15-17. Finally, ILC3 require the transcription factors retinoic acid 
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receptor-related orphan receptor-γt (RORγt) and aryl hydrocarbon receptor (AhR) and 
include mucosal NK-22 cells, which secrete IL-22 and thus mimic non-inflammatory TH22 
cells18-21, as well as fetal and mucosal lymphoid tissue inducer (LTi) cells, which produce 
IL-22 and IL-17 and thus resemble pro-inflammatory TH17 cells22-24. While NK-22 cells 
express natural cytotoxicity receptors (NCRs) usually associated with NK cells and mediate 
mucosal homeostasis by targeting epithelial cells via IL-22 (refs. 25-27), LTi cells lack 
NCRs and promote fetal lymphoid organogenesis and post-natal mucosal immunity by 
targeting stromal cells via lymphotoxin (LT) and tumor necrosis factor (TNF)28-30.
Mucosal NK-22 cells, also defined as NCR+ ILC3 to distinguish them from inflammatory 
NCR– ILC3 characterized by constitutive IL-17, IL-22 and activation-induced IFN-γ 
production31, 32, express B cell-activating factor of the TNF family (BAFF)20, a cytokine 
used by DCs, macrophages and neutrophils to help MZ B cells and plasma cells in a T cell-
independent (TI) manner1, 9, 10. BAFF and its homologue a proliferation-inducing ligand 
(APRIL) are related to CD40 ligand (CD40L), a TNF family member used by T follicular 
helper (TFH) cells to activate FO B cells33. Given their involvement in mucosal TI antibody 
production29, 34, ILCs could regulate humoral immunity also in the MZ, a lymphoid area 
that is continually exposed to antigen as are mucosal membranes.
Here we identified ILCs with mucosa-like properties in the MZ and perifollicular zone of 
the spleen. These ILCs required survival signals from marginal reticular cells (MRCs), a MZ 
subset of stromal cells that responded to TNF and LT from ILCs. In addition to stimulating 
MZ B cells and plasma cells via BAFF, APRIL, CD40L and the NOTCH2 ligand Delta-like 
1 (DLL1), splenic ILCs co-opted MZ B cell-helper neutrophils via granulocyte monocyte-
colony stimulating factor (GM-CSF). Consequently, ILC depletion hampered MZ B cell 
production of antibodies to TI antigens.
RESULTS
Splenic ILCs have type-3 mucosal features
The MZ is continually exposed to blood-borne antigens and may thus require homeostatic 
signals from ILCs as mucosal membranes do4. Flow cytometry showed that histologically 
normal adult human spleens contained cells that lacked common lymphoid and myeloid 
lineage (Lin)-associated molecules, but expressed the IL-7 receptor CD127 and the stem cell 
growth factor receptor CD117 (Fig. 1a and Supplementary Fig. 1a). These ILCs resembled 
mucosal NCR+ ILC3s19, 20, because they expressed the NK cell molecules CD56, CD96, 
CD161, NKp44 and NKp46, the CCL20 chemokine receptor CCR6, the activation 
molecules CD25 and CD69, and NOTCH2 (Fig. 1a and Supplementary Figs. 1b). Splenic 
ILCs expressed neither the CD8 co-receptor, which is associated with cytotoxic T cells, nor 
the integrin CD103, which is expressed by some mucosal lymphocytes, nor the CD4 co-
receptor and the prostaglandin D2 receptor CRTH2 (Fig. 1a and Supplementary Fig. 1b), 
which are expressed by mouse LTi cells and human ILC2, respectively16, 22. Albeit 
expressing as much CD161 as NK cells, splenic ILCs showed more NKp44, CCR6 and 
CD96 but less NKp46 than NK cells did (Supplementary Fig. 1c).
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Gene expression studies performed through quantitative reverse transcription-polymerase 
chain reaction (qRT-PCR) showed that splenic ILCs expressed the transcription factors 
RORγt, AhR and Id2, the cytokines IL-22, IL-26, LT-α, LT-β and TNF and the IL-23 
receptor, whereas splenic NK cells, T cells and macrophages did not, except B cells that 
expressed abundant LT-β (Fig. 1b and Supplementary Fig. 1d). Compared to mucosal 
ILCs from tonsils, splenic ILCs expressed comparable RORγt and AhR, but less IL-22 and 
more LT-α, LT-β and TNF (Fig. 1b). These latter cytokines are also hallmarks of LTi cells 
together with IL-17 (refs. 23, 30). However, splenic ILCs lacked IL-17, which was instead 
detected in T cells (Supplementary Fig. 1d). Of note, splenic ILCs included CD56+ and 
CD56– subsets with an overlapping ILC3 gene expression profile that did not include IFN-γ 
and Perforin-1, which were instead abundant in NK cells (Fig. 1b and Supplementary Fig. 
1e,f). Flow cytometry showed that splenic RORγt+ ILCs lacked T-bet, a transcription factor 
that was instead expressed by RORγt– NK cells (Fig. 1c).
Flow cytometry and enzyme-linked immunosorbent assay (ELISA) demonstrated that 
splenic ILCs were more abundant than mucosal ILCs (Fig. 1d) and displayed NCR+ ILC3 
properties19, 20. Indeed, splenic ILCs received anti-apoptotic signals from the stromal 
cytokine IL-7 and the innate cytokines IL-1β and IL-23 and secreted IL-22 in response to 
IL-1β and IL-23 as mucosal ILCs did (Fig. 1e,f). Finally, tissue immunofluorescence 
analysis (IFA) and immunohistochemistry (IHC) showed that 
RORγt+NKp44+CD117+tryptase– ILCs occupied MZ and perifollicular zone (PFZ) areas 
and were distinct from CD117+tryptase+ mast cells and CD3+RORγt–NKp44– T cells (Fig. 
1g,h and Supplementary Fig. 2a-d). Some ILCs were also found in the periarteriolar 
lymphoid sheath (not shown). Thus, the human spleen contains mucosa-like ILCs different 
from NK cells and positioned nearby MZ B cells.
Splenic ILCs receive survival signals from MRCs
Given that LTi cells interact with stromal cells via LT and TNF22, 29, 30, we sought to 
identify stromal cells in the human MZ by tissue IFA, IHC and flow cytometry. Fibroblast-
like cells expressing mucosal addressing cell adhesion molecule-1 (MAdCAM-1) were 
detected in the MZ nearby IgD+ B cells and some RORγt+ ILCs (Fig. 2a and 
Supplementary Fig. 3a). These MAdCAM-1+ cells did not express the coagulation protein 
von Willebrand factor (vWF), which characterizes endothelial cells, whereas MAdCAM-1– 
sinusoid-lining cells (SLCs) from the red pulp did (Fig. 2a). MAdCAM-1+ cells also lacked 
the endothelial molecules platelet endothelial cell adhesion molecule-1 (PECAM-1) and 
CD34 as well as the leukocyte molecule CD45, but expressed the stromal molecules Thy-1 
(or CD90), CD141 (thrombomodulin), intercellular adhesion molecule-1 (ICAM-1), 
vascular cell adhesion molecule-1 (VCAM-1) and α-smooth muscle actin (Fig. 2b and 
Supplementary Fig. 3b,c), and were thus considered equivalent to mouse MRCs3.
Human MRCs expressed TLR3, which binds double-stranded RNA, TLR4, which binds 
lipopolysaccharide (LPS), and TLR9, which binds unmethylated CpG-rich DNA (Fig. 2b), 
pointing to a role of microbial products in the regulation of MRCs. Laser capture 
microdissection followed by qRTPCR demonstrated that MRC-enriched MAdCAM-1+ 
tissue contained more ILC survival factors such as IL-1β, IL-7 and IL-23 and more ILC-
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recruiting factors such as CCL20 (a CCR6 ligand) than SLC-enriched mannose receptor 
(MR, an endocytic receptor)+ tissue or control MR– tissue (Fig. 2c).
As shown by flow cytometry, splenic ILCs up-regulated the MAdCAM-1-binding integrin 
α4β7 in response to IL-7 and IL-1β, pointing to a role of MAdCAM-1-α4β7 interaction in the 
perifollicular positioning of ILCs. Conversely, MRCs up-regulated ICAM-1 and VCAM-1 
in response to splenic ILCs or a combination of LT and TNF or LPS (Fig. 2d and 
Supplementary Fig. 3d,e). Blocking experiments and qRT-PCR indicated that ILCs 
activated MRCs via LT and TNF, whereas MRCs up-regulated IL-7, CCL20 and 
MAdCAM-1 in response to LT and TNF (Fig. 2e and Supplementary Fig. 3f,g). Of note, 
transwell assays showed that MRCs supported ILC survival via contact-dependent and 
contact-independent signals that included IL-7 (Fig. 2g,h). Finally, splenic macrophages and 
DCs expressed more IL-1β and IL-23 than MRCs (Supplementary Fig. 3h), suggesting that 
ILCs establish a bi-directional interplay with MRCs in splenic niches that may also entail 
innate immune cells.
Splenic ILCs and MRCs deliver B cell-helper signals
Given their MZ and perifollicular location, human splenic ILCs may regulate MZ B cells. 
As shown by tissue IFA and qRT-PCR, splenic RORγt+ ILCs were positioned nearby 
CD20+ B cells and, compared to other splenic leukocyte subsets or mucosal ILCs, expressed 
more BAFF, CD40L and DLL1 (Fig. 3a,b), three major B cell and plasma cell helper 
factors5, 9, 10, 35. Unlike splenic macrophages, splenic ILCs expressed little or no APRIL 
(Fig. 3b), a BAFF-related plasma cell survival factor36.
As shown by flow cytometry and ELISA, splenic ILCs expressed surface BAFF, CD40L 
and DLL1 and secreted BAFF, whereas APRIL was mainly secreted by macrophages (Fig. 
3c,d). Accordingly, splenic ILCs stimulated the survival, proliferation, IgM secretion and 
plasmablast differentiation of IgDloCD27+ MZ but not IgDhiCD27– FO B cells (Fig. 3e-g). 
Having shown that MRCs provide survival and activation signals to ILCs, we verified 
whether MRCs augmented the B cell-helper function of ILCs. Compared to MZ B cells 
exposed to ILCs or MRCs alone, MZ B cells exposed to both ILCs and MRCs not only 
underwent more IgM secretion and plasmablast differentiation, but also acquired the ability 
to release IgG and IgA, particularly in the presence of CpG DNA (Fig. 3f,g). Thus, human 
splenic ILCs may integrate stromal and innate immune signals to orchestrate antibody 
production.
Splenic ILCs help MZ B cells via BAFF, CD40L and DLL1
Next, we used flow cytometry and ELISA to determine the mechanism by which human 
splenic ILCs help MZ B cells. BAFF-R-Ig, a soluble decoy receptor that blocks the binding 
of BAFF to B cells, attenuated the survival of MZ B cells exposed to ILCs (Fig. 4a). Of 
note, MZ B cells underwent plasmablast differentiation and IgM secretion in response to 
ILCs but not ILC-conditioned medium (Fig. 4b,c), suggesting the involvement of contact-
dependent signals from membrane-bound BAFF, CD40L and/or DLL1. Accordingly, 
BAFF-R-Ig, CD40-Ig or a NOTCH signaling inhibitor mitigated ILC-induced IgM 
secretion, particularly when these inhibitors were used in combination (Fig. 4d).
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Although required for the early development of MZ B cells, NOTCH2 remains expressed on 
mature MZ B cells and may thus modulate their function5. Indeed, when combined with 
BAFF, DLL1-expressing OP9 stromal cells stimulated plasma cell differentiation and IgM 
secretion through NOTCH signals in MZ B cells (Fig. 4e-g). In contrast, BAFF alone or 
combined with DLL1-negative OP9 cells had little or no stimulatory effect (Fig. 4e-g). 
Thus, besides eliciting MZ B cell survival and activation, human splenic ILCs promote 
plasmablast differentiation and survival via BAFF, CD40L and DLL1.
Splenic ILCs activate perifollicular neutrophils via GM-CSF
In human spleens, MZ B cells interact with neutrophils (termed NBH cells) possibly 
originating from circulating precursors (termed NC cells)10. Given the involvement of 
RORγt in GM-CSF expression by TH17 cells and the important role of GM-CSF in 
neutrophil activation and survival37, we wondered whether splenic ILCs expressed GM-
CSF. Tissue IHC showed CD117+ ILCs nearby CD66 (CEACAM-1)+ NBH cells positioned 
around the MZ (Fig. 5a). qRT-PCR, ELISA and flow cytometry demonstrated the 
expression of abundant GM-CSF in splenic ILCs, but not other leukocyte subsets (Fig. 
5b,c). Splenic ILCs further expressed the neutrophil-recruiting chemokine IL-8 (or CXCL8), 
which was also produced by macrophages and NK cells, albeit in lesser amounts (Fig. 5b,c).
Given that GM-CSF enhances the B cell-helper function of neutrophils10, we used flow 
cytometry, ELISA, IFA and qRT-PCR to establish whether GM-CSF-producing splenic 
ILCs induce NBH cell-like properties to NC cells. In the presence of splenic ILCs, NC cells 
not only acquired phenotypic traits typical of NBH cells10, such as up-regulation of the 
activation molecules CD69, CD11b and CD24 and down-regulation of the adhesion 
molecule CD62 ligand (CD62L), but also received survival signals from GMCSF (Fig. 
5d,e). When incubated with splenic ILCs or their conditioned medium, NC cells up-
regulated APRIL and thus stimulated more IgA production in MZ B cells (Fig. 5f,g). ILC-
conditioned medium also augmented the capacity of NBH cells to induce IgM, IgG and IgA 
in MZ B cells (Fig. 5h). Similar to GMCSF or LPS, ILC-conditioned medium stimulated NC 
cells to form neutrophil extracellular traps (NETs) (Fig. 5i), which are antigen-trapping 
projections often emanating from NBH cells10. Thus, human splenic ILCs may amplify MZ 
B cell responses by stimulating perifollicular neutrophils via GM-CSF.
Splenic ILCs enhance TI antibody production
To elucidate the in vivo contribution of splenic ILCs to humoral immunity, we initially took 
advantage of Rorc–/– mice, which lack the RORγt transcription factor required for the 
development of ILC3 (refs. 22, 28). Rorc–/– mice also lack TH17 cells, a subset of CD4+ T 
cells that regulate neutrophils via IL-17 and GM-CSF37-39. Flow cytometry showed that 
Rorc–/– mice had fewer splenic Lin–CD117+CD127+ ILCs than Rorc+/+ mice (Fig. 6a). In 
these wild type mice, flow cytometry and qRT-PCR demonstrated that splenic ILCs 
included both CD4+ and CD4– subsets that expressed more RORγt, IL-22, LT-α and TNF 
than did other splenic leukocytes (Fig. 6b and Supplementary Fig. 4a). In contrast to 
human splenic ILCs, mouse splenic ILCs lacked BAFF and CD40L, but expressed APRIL 
and DLL1 (Fig. 6b).
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We then verified whether Rorc–/– mice had an altered MZ. As shown by tissue IFA, Rorc–/– 
mice had no perturbations of either MOMA1+ metallophilic macrophages, ER-TR9+ MZ 
macrophages and ICAM-1+ marginal sinus cells from the MZ or IgM+ B cells from the MZ 
and white pulp or F4/80+ macrophages and VCAM-1+ endothelial cells from the red pulp 
(Supplementary Fig. 4b). Flow cytometry, tissue IFA and ELISA demonstrated that 
spleens from non-immunized Rorc–/– mice contained conserved B cells, but fewer 
plasmablasts and plasma cells expressing IgG3 (Fig. 6c,d and Supplementary Fig. 5a), an 
antibody produced by MZ B cells through a TI pathway under pre-immune conditions or 
after immunization40, 41. Besides less total serum IgG3, Rorc–/– mice had less serum IgG3 to 
the bacterial TI antigen phosphorylcholine (PC) (Fig. 6e,f). To ascertain the relative 
contribution of ILCs and T cells to pre-immune IgG3 responses, Rorc+/– and Rorc–/– mice 
were crossed with T cell-deficient Cd3e–/– mice. In agreement with the TI nature of pre-
immune IgG3 production40, 41, non-immunized Rorc+/–Cd3e–/– mice had normal pools of 
splenic B cells, plasma cells and plasmablasts expressing IgG3 (Fig. 6g). Compared to these 
mice, Rorc–/–Cd3e–/– mice showed conserved B cells, but fewer plasmablasts and plasma 
cells expressing IgG3 and less pre-immune serum IgG3 (Fig. 6g,h).
Unlike pre-immune serum IgG3, pre-immune serum IgM was augmented in Rorc–/– mice 
together with splenic IgMhiB220int/loCD5int B-1 cells but not B220+CD21+CD23+ FO B 
cells and B220+CD21hiCD23– MZ B cells (Supplementary Fig. 5b,c). The expansion of 
IgM-producing B-1 cells in Rorc–/– mice may result from enhanced migration of B-1 cells 
from the peritoneal cavity to the spleen due to the lack of gut-associated lymphoid tissue and 
increased systemic translocation of gut bacteria22, 28, 34, 42. Nonetheless, Rorc–/– mice had 
less pre-immune serum IgM to PC (Supplementary Fig. 5d), suggesting a role of ILCs in at 
least some TI IgM responses.
To dissect the MZ B cell-helper function of ILCs in a more physiological model, an anti-
Thy-1.2 antibody was used to deplete ILCs in Thy-1-disparate Rag1–/– chimeric mice 
generated as described in a recently published study43. Compared to mice treated with a 
control antibody, mice treated with anti-Thy-1.2 showed fewer splenic ILCs, fewer IgG3-
expressing plasmablasts and plasma cells, and reduced pre-immune serum IgG3 (Fig. 7a-c 
and Supplementary Fig. 5e). Furthermore, anti-Thy-1.2-treated mice had impaired post-
immune IgG3 responses to 2,4,6-trinitrophenyl (TNP)-Ficoll (Fig. 7d), a TI antigen that 
induces antibody production in innate-like B cells, including MZ B cells40.
The involvement of splenic ILCs in TI antibody production was also demonstrated by 
reconstituting lethally irradiated Rorc–/– mice with a mix of bone marrow cells from Rag1–/– 
mice – which generate ILCs but not T and B cells – and Rorc–/– mice – which generate T 
and B cells but not ILCs. ILC-sufficient (ILC+) chimeric mice developed splenic ILCs, 
whereas control ILC– mice generated by reconstituting irradiated Rorc–/– mice with bone 
marrow cells from Rorc–/– mice did not (Fig. 7e). Compared to ILC+ mice, ILC– mice 
showed fewer splenic plasmablasts and plasma cells expressing IgG3 and less pre-immune 
serum IgG3 (Fig. 7f,g). In all mouse models, IgM responses were only marginally affected 
(not shown), indicating that splenic ILCs predominantly help IgG3-expressing plasmablasts 
and plasma cells emerging from MZ B cell responses to TI antigens.
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Splenic ILCs regulate neutrophil homeostasis
We next determined the role of mouse splenic ILCs in the homeostasis of NBH cells. Tissue 
IFA and flow cytometry showed that ILC– bone marrow chimeric mice had fewer splenic 
Ly6G+CD11b+ neutrophils and extrafollicular IgG3-producing plasmacytes than control 
ILC+ mice (Fig. 8a,b). Splenic neutrophils were also decreased in Rorc–/– mice with either a 
T cell-sufficient or T cell-deficient background (Supplementary Fig. 6a-c), indicating that 
splenic ILCs provide helper signals to neutrophils independently of T cells. To ascertain the 
contribution of splenic neutrophils to pre-immune IgG3 production, ILC-reconstituted 
(ILC+) bone marrow chimeric mice were depleted of splenic neutrophils with an anti-Ly6G 
antibody (Fig. 8c). These mice had normal splenic ILCs and IgG3-expressing B cells and 
plasmablasts, but fewer splenic IgG3-expressing plasma cells and decreased pre-immune 
serum IgG3 compared to ILC+ mice treated with a control antibody (Fig. 8d-f). Thus, unlike 
ILCs, neutrophils may predominantly control terminally differentiated IgG3-secreting cells.
Finally, we determined whether splenic ILCs regulate neutrophils via GM-CSF. As shown 
by qRTPCR, splenic ILCs from wild-type mice expressed more GM-CSF than other 
leukocyte subsets did, including macrophages and NK cells (Fig. 8g). Compared to controls, 
GM-CSF (also known as colony-stimulating factor 2)-deficient Csf2–/– mice had reduced 
pre-immune serum antibodies to bacterial PC and fewer splenic neutrophils, which increased 
after inoculation of GM-CSF-expressing B16 melanoma cells (Fig. 8h and Supplementary 
Fig. 6d). Also Rag1–/–Il2rg–/– mice, which lack the IL-2 receptor common γ chain 
mandatory for IL-7-dependent ILC development13, had fewer splenic neutrophils compared 
to Rag1–/–Il2rg+/+ controls (Fig. 8i). Moreover, adoptive transfer of ILCs from Csf2+/+ but 
not Csf2–/– mice increased splenic neutrophils in Rag1–/–Il2rg–/– mice (Fig. 8i). Thus, in 
addition to helping MZ B cells and plasma cells through BAFF (or APRIL), CD40L and 
DLL1, splenic ILCs co-opt neutrophils via GM-CSF to enhance TI antibody production 
(Supplementary Fig. 7a,b).
DISCUSSION
We have shown that the MZ and PFZ of the spleen contained group-3 mucosa-like ILCs that 
released LT and TNF to establish a bi-directional crosstalk with stromal MRCs. In addition 
to stimulating MZ B cells and plasma cells through BAFF, APRIL, CD40L and DLL1, 
splenic ILCs co-opted neutrophils with MZ B cell- and plasma cell-helper functions through 
GM-CSF, thereby sustaining TI antibody production.
Mucosal and serosal membranes contain evolutionarily primitive lymphocyte subsets that 
include B-1 cells, γδ T cells, invariant NKT cells and mucosa-associated invariant T cells44. 
By sensing conserved microbial signatures through somatically recombined and germline-
encoded receptors, these innate-like lymphocytes rapidly activate protective programs that 
crossover the conventional boundaries between the innate and adaptive immune systems44. 
Mucosal membranes also contain ILCs that lack somatically recombined receptors and yet 
mount prompt T cell-like responses13. Here, we found that splenic ILCs enhanced antibody 
production to TI antigens by activating innate-like B cells positioned at the interface 
between the immune and circulatory systems.
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Similar to mucosal ILC3 (refs. 19, 20), human splenic ILCs contained both RORγt and AhR 
transcription factors, expressed NCRs along with various activation molecules, and secreted 
IL-22 in response to IL-23. In addition, human splenic ILCs activated MZ-based stromal 
MRCs via LT and TNF and thus also resembled fetal or mucosal LTi cells28-30, 45. 
However, unlike LTi cells23, 30, human splenic ILCs did not express IL-17, raising questions 
as to the ontogenetic relationship between these ILC subsets. Mouse splenic ILCs had a 
phenotype and gene expression profile similar to those of human splenic ILCs, but 
expressed CD4, thus showing a closer affiliation with LTi cells.
Human splenic ILCs not only expressed the gut homing receptor α4β7, but also interacted 
with MRCs equipped with MAdCAM-1, an α4β7 ligand usually associated with gut 
endothelial cells34. Given their additional expression of CCL20 and the presence of the 
CCL20 receptor CCR6 on splenic ILCs, MRCs might be involved in the positioning of ILCs 
within and around the MZ. Consistent with their stroma phenotype and reticular 
morphology, MRCs lacked endothelial molecules and exhibited strong responsiveness to LT 
and TNF from ILCs, thus resembling MAdCAM-1+ stromal cells lining the mouse marginal 
sinus46. Conversely, MRCs delivered both contact-dependent and contact-independent 
survival signals to ILCs, including IL-7. Remarkably, MRCs increased IL-7 expression in 
response to LT and TNF, pointing to the presence a bi-directional functional crosstalk 
between MRCs and ILCs in the MZ and PFZ of the spleen. Additional ILC survival factors 
such as IL-1β and IL-23 were predominantly expressed by splenic DCs and macrophages, 
suggesting that ILCs inhabit a splenic niche that entails survival signals from both stromal 
and immune cells. Of note, MRCs received further activation signals from TLR ligands such 
as LPS, lending support to the possibility that commensal antigens from the intestinal 
mucosa help the post-natal development and function of the splenic MZ4, 10, 47, 48.
In humans, splenic ILCs enhanced the survival of MZ B cells through a contact-independent 
mechanism involving soluble BAFF, but triggered the differentiation of MZ B cells into 
plasmablasts through contact-dependent signals provided by membrane-bound BAFF, DLL1 
and CD40L. Of note, DLL1 synergized with soluble BAFF to induce IgM secretion, 
possibly owing to the pro-survival effect of soluble BAFF on plasmablasts35. Given that 
DLL1 also cooperates with BAFF to stimulate the early development of MZ B cells5, there 
is the possibility that DLL1 on ILCs operates at both early and late stages of MZ B cell 
differentiation with distinct signaling programs. Of note, splenic ILCs further helped MZ B 
cells by co-opting NBH cells through GM-CSF. This cytokine may also enhance the MZ B 
cell-stimulating function of DCs and possibly macrophages1, 4, which may explain why a 
relative small number of ILCs is sufficient to enhance TI antibody responses.
Despite expressing CD40L, a class switch-inducing factor typically detected on TFH cells33, 
human splenic ILCs did not trigger IgG or IgA production in MZ B cells. Nonetheless, MZ 
B cells induced IgA and IgG when exposed to ILCs in the presence of MRCs and microbial 
TLR ligands. Accordingly, small amounts of these bacterial components can be detected in 
splenic perifollicular areas together with plasma cells releasing IgM, IgG or IgA10. Thus, 
similar to gut LTi cells29, splenic ILCs may integrate stromal and innate immune signals to 
rapidly generate antibodies for antimicrobial protection.
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Although lacking both CD40L and BAFF, mouse splenic ILCs expressed APRIL, a BAFF-
related molecule that enhances plasma cell survival36. By also expressing DLL1, mouse 
splenic ILCs would sustain the differentiation and/or survival of plasmablasts and plasma 
cells emerging during IgG3 responses to TI antigens. In mice, ILC depletion did not impair 
IgM production, suggesting that ILCs predominantly enhance MZ B cell-derived IgG3 
rather than B-1 cell-derived IgM responses. Nonetheless, splenic ILCs sustained pre-
immune production of IgM to bacterial PC, which points to the involvement of ILCs in IgM 
responses to some but not all TI antigens.
In ILC-deficient mice, impaired TI IgG3 production was associated with a reduction of NBH 
cells, which help MZ B cells via BAFF and APRIL10. Accordingly, human splenic ILCs 
enhanced the survival and B cell-helper activity of NBH cells through GM-CSF. This 
cytokine also induced NET-like structures, which might enable NBH cells to capture blood-
borne antigens transiting through the MZ4, 10. Human splenic ILCs also released IL-8, 
which may contribute to the recruitment of NBH cells. Mice do not express IL-8, but their 
splenic ILCs may attract NBH cells via alternative factors, including GM-CSF. Remarkably 
also splenic innate response activator (IRA) B cells express GM-CSF49, which could explain 
the persistence of some NBH cells in mice lacking ILCs.
GM-CSF further derives from TH17 cells37, but the analysis of T cell-deficient mice 
suggested that ILCs can regulate the homeostasis of NBH cells independently of T cells. In 
mice, splenic ILCs sustained both IgG3+ plasmablasts and IgG3+ plasma cells, whereas 
mouse NBH cells predominantly helped IgG3+ plasma cells, suggesting that multiple subsets 
of innate immune cells orchestrate TI IgG3 responses in a hierarchical manner. Of note, 
IgG3 may provide protection against certain pathogens following its interaction with 
ficolins, a family of soluble pattern recognition receptors released by hepatocytes and 
various cells of the innate immune system41. In summary, our studies indicate that splenic 
ILCs orchestrate a stromal-innate cell network that fosters TI antibody production by MZ B 
cells. Harnessing this network with adjuvants may enhance protective humoral responses to 




Mononuclear cells and neutrophils were isolated from the peripheral blood of healthy 
volunteers or histologically normal spleens from deceased organ donors or splenectomized 
trauma patients without clinical signs of infection or inflammation10. Tonsils were from 
individuals with follicular hyperplasia10. The use of blood and tissues was approved by the 
Ethical Committee for clinical investigation of Institut Hospital del Mar d'Investigacions 
Mèdiques (CEIC-IMIM 2011/4494/I). Tissue samples were collected by the department of 
Pathology of Hospital del Mar. Prior to collection, signed informed consent was obtained 
from the patient or his/her parent or guardians. All the blood and tissue samples were coded 
and relevant clinical information remained anonymous.
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Rorc–/– (Rorcgfp/gfp), Cd3e–/–, Rag1–/–, Rag1–/–Il2rg–/– and Csf2–/– mice on the C57BL/6 
background have been described previously29,51-54. C57BL/6 CD90.1 mice were purchased 
from the Jackson Laboratory. All mice were housed in specific pathogen-free conditions. 
Male and female mice were used at age 8-12 weeks unless specified in the text. All the 
experiments involving mice were performed in accordance with approved protocols from the 
Institutional Animal Care at RIKEN and Icahn School of Medicine at Mount Sinai.
Mouse chimeras and neutrophil depletion
4 × 107 bone marrow cells from Rag1–/– mice were mixed with 1 × 107 bone marrow cells 
from Rorc–/– mice and injected intravenously into 10-Gy irradiated 2-month old Rorc–/– 
mice. After transplantation, mice were given 500 mg/L ampicillin (Sigma) and 1 g/L 
neomycin (Sigma) in drinking water for 2 weeks. To deplete neutrophils, control RTK2758 
monoclonal antibody (mAb) or neutrophil-depleting 1A8 mAb to Ly6G (BioXCell) were 
administrated intraperitoneally every 5 days at a dose of 250 μg/mouse for a month. Thy-1 
disparate Rag1–/– chimeras were generated and depleted of ILCs with a 30-H12 mAb to 
Thy-1.2 (BioXCell) injected intraperitoneally every 3 days at a dose of 500 μg/mouse for a 
month as previously published43. LTF-2 mAb was used as control.
Adoptive transfers
2–3 × 104 ILCs from the small intestine of either Csf2+/+ or Csf2–/– mice were adoptively 
transferred into Rag1–/–Il2rg–/– mice via retro orbital injection as previously described and 
splenic neutrophils were analyzed 21 days later. 1 × 105 B16Csf2 melanoma cells 
overexpressing GM-CSF (from G. Dranoff) were injected into Csf2–/– mice and splenic 
neutrophils were analyzed 12–14 days later.
Immunization
Serum TNP-specific antibody titers were determined by ELISA 7 days after intraperitoneal 
injection of 50 μg TNP-Ficoll.
Cells
Human splenocytes or tonsillar mononuclear cells were obtained from fresh tissue samples 
as reported in published studies10. Human ILCs, NK cells, naïve B cells, MZ B cells, 
macrophages, T cells, NC cells and NBH cells were sorted by flow cytometry as described 
previously10 or reported below. To isolate human MRCs, splenic tissues were enzymatically 
digested in Hank's balanced salt solution (Lonza) containing 1 mg/ml collagenase-IV 
(Invitrogen) and 50 ng/ml DNAse-I (50 ng/ml) at 37 °C for 45 min, followed by separation 
on Ficoll-Hypaque gradient. Splenocytes were resuspended in EGM medium (Lonza) and 
cultured in 0.1% gelatin (Sigma) pre-coated plate. 72 h later, adherent cells were obtained 
with Accutase cell detachment solution as instructed by the manufacturer (Millipore). 
CD45– CD31– adherent cells were sorted by flow cytometry and expanded up to three 
passages in EGM medium. Murine OP9 and OP9-DLL1 stromal cell lines (from R. Gimeno) 
were tested for mycoplasma and grown in essential medium-α (Invitrogen) supplemented 
with 20% Fetalclone I (Hyclone).
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Human splenic ILCs (5 × 104/well) were plated in 96 U-bottom plates and cultured in 
complete RPMI medium with or without 50 ng/mL IL-7, 50 ng/mL IL-1β and/or 50 ng/mL 
IL-23 (Peprotech). Conditioned medium was obtained by culturing splenic ILCs in complete 
medium for 24 h. In co-culture experiments, splenic ILCs were first expanded with IL-7 and 
IL-1β for 5-8 days as previously published. ILCs were co-cultured with confluent human 
MRCs in flat-bottom plates for 72 h. To avoid cell-to-cell contact, some co-cultures were 
performed in a 24-transwell system (Corning). Human ILCs were also co-cultured with 
human MZ B cells, NC cells and/or NBH cells at a 1:10 ratio. Some co-cultures were 
supplemented with 500 ng/ml BAFF (Alexis), 0.25 μg/ml CpG ODN-2006 (InvivoGen), 30 
μg/ml BAFF-R-Ig, 5 μg/ml CD40-Ig, 5 μg/ml, 10 μg/ml neutralizing MAB215 mAb to 
human GM-CSF, or 10 μg/ml isotype control IgG1 mAb (R&D system). To inhibit 
NOTCH2, human MZ B cells were incubated with 25, 5 or 2.5 μM N-[N-(3,5-
difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT) (Sigma), which 
interferes with the cleavage of NOTCH proteins by γ-secretase. In some experiments, 
human MRCs were stimulated with 100 ng/ml LTα1β2 and 10 ng/ml TNF (R&D Systems) 
or with ILCs in the presence or absence of 10 μg/ml mAbs MAB2101 to TNF or MAB1370 
to LTα2β1/α1β2 (R&D Systems). Human NC cells were stimulated with 50 ng/ml GM-CSF 
(Peprotech) or 100 ng/ml LPS (InvivoGen).
Flow cytometry
Cells were incubated with Fc blocking reagent (Miltenyi Biotec) at 4 °C before adding 
appropriate cocktails of fluorochrome-labeled mAbs (Supplementary Tables 1 and 2). 
Dead cells were excluded with 4’-6-diamidine-2’-phenylindole (DAPI) as indicated by the 
manufacturer (Boehringer Mannheim). To stain intracellular transcription factors, human 
ILCs or NK cells were stained with mAbs to cell-specific surface molecules, permeabilized, 
fixed with a Transcription Factor Buffer Set as indicated by the manufacturer (eBioscience), 
and labeled with mAbs to human RORγt or T-bet (Supplementary Table 1). For 
intracellular cytokine staining, human ILCs were cultured for 4 h in complete RPMI 
medium with GolgiStop (BD Pharmingen) in the presence or absence of 10−7 M phorbol 
myristate acetate and 0.5 μg/ml ionomycin (Sigma). These cells were stained with mAbs to 
specific surface molecules, fixed, permeabilized using the Cytofix/Cytoperm kit (BD 
Pharmingen), and finally incubated with mAbs to human GM-CSF or IL-8 (Supplementary 
Table 1). To stain intracellular IgG3, mouse splenocytes were stained with mAbs to specific 
surface molecules, permeabilized, fixed with the Cytofix/Cytoperm kit (BD Pharmingen), 
and labeled with R40-82 mAb to mouse IgG3 (Supplementary Table 2). Cells were 
acquired using FACS calibur, FACS Aria II, LSRII or LSRFortessa (BD Biosciences) and 
further analyzed using the FlowJo software (Tree Star).
FACSorting
Human CD3–CD14–CD19–CD117+CD127+ ILCs, CD3–CD14–CD19–CD117–CD127– 
CD56+ NK cells, CD19+IgDhiCD27– naïve B cells, CD19+IgDloCD27+ MZ B cells, CD14+ 
macrophages and CD3+ T cells as well as mouse CD3+ T cells, B220+ B cells, CD11c+ 
DCs, CD11b+ macrophages, CD49b+ NK cells, Ly6G+ neutrophils, 
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CD4+CD45+CD117+CD127+Lin– (CD3–B220–CD11b–CD11c– Ly6G–) ILCs and 
CD4–CD45+CD117+CD127+Lin– ILCs were stained with appropriate cocktails of 
fluorochrome-labeled mAbs (Supplementary Tables 1 and 2) and sorted using FACSAria 
II (BD Biosciences) after exclusion of dead cells through DAPI staining. The purity of 
FACSorted cells was consistently > 95%.
Viability and proliferation assays
Cell survival was measured using the Annexin-V Apoptosis Detection Kit II (BD 
Pharmingen). Gates and quadrants were drawn to give ≤ 1% total positive cells in samples 
incubated with isotype control mAbs. Cell proliferation was assessed by CFSE staining 
using the CellTrace CFSE Cell Proliferation Kit (Invitrogen).
Laser capture microdissection
Microdissections were perfomed on fresh human splenic tissues frozen in optimal cutting 
temperature (OCT) compound using the ArcturusXT Laser Capture Microdissection System 
following the manufacturer's instructions (Life Technologies). In brief, 10-μm tissue slices 
were isolated on membrane slides (Life Technologies) and fixed in cold acetone for 10 s. 
Immunohistochemistry with specific mAbs was followed by tissue dehydration and fixation 
with xylene. Groups of cells from completely dried tissues were acquired by microdissection 
and RNA was extracted using the Arcturus PicoPure RNA Extraction Kit (Life 
Technologies).
Immunofluorescence analysis
Frozen tissues and cells from humans or mice were fixed as previously published10 and 
stained with various combinations of Abs (Supplementary Tables 1 and 2). Biotinylated 
Abs were detected using horseradish peroxydase (HRP)-conjugated streptavidin followed by 
tetramethylrhodamine from a Tyramide Signal Amplification Kit (PerkinElmer Life 
Sciences) or streptavidin-Alexa Fluor conjugates. Nuclear DNA was stained with DAPI. 
Coverslips were applied with FluorSave reagent (Calbiochem). Images were obtained using 
Axioplan2 (Carl Zeiss) microscopy and further analyzed using Axiovision (Carl Zeiss) 
software. To perform NET formation assays, human circulating neutrophils were seeded on 
poly D-lysin coated glass cover slips and stimulated for 3 h with either human GM-CSF or 
human splenic ILC-conditioned medium. Cells were fixed with 4% paraformaldehyde and 
stained with mAbs NP57 or ab21595 to human elastase and DAPI.
Immunohistochemistry
5-μm thick formalin-fixed and paraffin-embedded tissue sections were stained with various 
mAbs (Supplementary Table 1) using EnVision™ + Dual Link System-HRP (DAB+) for 
single stainings and EnVision G/2 Doublestain System Rabbit/Mouse (DAB+/Permanent 
Red) for double stainings (Dako). Sections were counterstained with hematoxylin.
ELISA
Total human IgM, IgG and IgA were measured as previously published10. Soluble human 
BAFF ELISA Kit (Adipogen), LEGEND MAX Human APRIL/TNFSF13 ELISA Kit 
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(Biolegend), Human GMCSF ELISA Development Kit, and Human IL-8 ELISA 
Development Kit (Peprotech) were used to measure human BAFF, APRIL, GM-CSF and 
IL-8. Human Th1/Th2/Th9/Th17/Th22 13plex FlowCytomix Multiplex (eBioscience) was 
used to measure human IL-17 and IL-22. The concentration of mouse serum IgM, IgG3 and 
IgA were determined with Mouse ELISA Quantification Set (Bethyl Laboratories). To 
detect mouse TNP-specific IgG3, ELISA plates coated with 5 μg/ml bovine serum albumin 
(BSA)-conjugated TNP (BioSearch Technologies) were sequentially incubated with mouse 
serum and HRP-conjugated goat polyclonal antibody A90-111P to mouse IgG3 (Bethyl 
Laboratories). To detect mouse phosphorylcholine-specific IgM, ELISA plates coated with 5 
μg/ml BSA-conjugated phosphorylcholine were sequentially incubated with serum and an 
HRP-conjugated goat polyclonal antibody A90-101P to IgM (Bethyl Laboratories). BSA-
conjugated phosphorylcholine was synthesized as follows. 1 mg of BSA was coupled to 1 
mg p-aminophenylphosphorylcholine in 0.1 M 2-(N-morpholino)ethanesulfonic buffer 
(Sigma) at pH 4.5 supplemented with 2 mg 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide 
hydrochloride in a 1.6 ml final volume. This mixture was incubated for 2 h at 20 °C. 
Conjugated BSA was dialyzed against PBS at pH 7.4 and 4 °C.
qRT-PCR
To quantify human gene products, total RNA was extracted and reverse transcribed into 
cDNA as reported in previously published studies10. qRT-PCRs were performed as reported 
previously10 using specific primer pairs (Supplementary Table 3). To quantify mouse gene 
products, total RNA was extracted with TRIzol reagent (Gibco BRL). After DNase I 
(Invitrogen) treatment, random hexamers (Invitrogen) were used for first-strand cDNA 
synthesis. qRT-PCRs were performed in 96-well plates with a LightCycler 480 real-time 
PCR instrument (Roche Diagnostics) using the LightCycler 480 SYBR Green I Master kit 
(Roche Diagnostics) and specific primer pairs (Supplementary Table 4). Gene expression 
was normalized to that of glyceraldehyde 3-phosphate dehydrogenase in each sample.
Statistical analysis
Values were expressed as mean ± standard error of the mean (s.e.m.) or standard deviation 
(s.d.). Statistical significance was assessed with two-tailed or one-tailed unpaired Student's t-
test unless specified otherwise. Mann-Whitney U-test or Wilcoxon matched-pairs signed 
rank test were performed on non-parametric data. Results were analyzed with Prism 
software (Graph Pad) and P values less than 0.05 were considered significant. In animal 
experiments, littermates (minimum 3 mice/group) were randomly distributed to the 
treatment groups so that all groups were age-matched and sex-matched. No specific 
randomization or blinding protocol was used and no animals were excluded from the 
analysis.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Human splenic ILCs express a mucosa-like group-3 phenotype and occupy MZ and 
perifollicular areas
(a) Flow cytometry of CD4, CD25, CD56, CD69, CD96, CD161, NKp44, NKp46 and 
CCR6 on splenic Lin–CD117+CD127+ ILCs (red gate). Gray shading, negative control. (b) 
qRT-PCR of RORC (RORγt), AHR (AhR), IL22 (IL-22), TNF (TNF), LTA (LT-α), LTB 
(LT-β), PRF1 (Perforin-1) and IFNG (IFN-γ) mRNAs from splenic or tonsillar ILCs and NK 
cells and from splenic macrophages (Mϕ), B cells and T cells. Results are normalized to 
ACTB (β-actin) mRNA and presented as relative expression (RE) compared with that of 
fresh splenic NK cells. Error bars, s.e.m.; *P <0.05 (two-tailed unpaired Student's t test). (c) 
Flow cytometry of intracellular RORγt and T-bet in splenic ILCs (red lines) and NK cells 
(blue lines). (d) Flow cytometry of Lin–CD117+CD127+ ILCs in splenic and tonsillar 
lymphocytes. *P < 0.05 (Mann-Whitney U-test). (e) Flow cytometric analysis of frequency 
of viable Annexin-V–propidium iodide (PI)– ILCs after culture of splenic and tonsillar ILCs 
with medium alone (Ctrl), IL-1β, IL-7 or IL-23 for 72 h. (f) ELISA of IL-22 from splenic 
and tonsillar ILCs cultured as in (e). (g) IFA of spleen stained for MR (purple), RORγt 
(green) and DNA-binding 4’-6-diamidine-2’-phenylindole (DAPI; blue). RP, red pulp. 
Original magnification, ×10. FO: center of the follicle (h) Immunohistochemical 
quantification of CD117+Tryptase– ILCs from MZ-PFZ and red pulp (RP) areas in nine 
microscopic ×20 fields from two spleens. *P< 0.05 (Wilcoxon Matched-pairs signed Rank 
test). Data summarize three measurements from three pooled experiments with 1 donor in 
each (spleen and tonsil) (b), display values from thirty seven spleens and twelve tonsils (d), 
or show one of four experiments with similar results (a,c,e,f,g).
Magri et al. Page 18













Figure 2. Human splenic ILCs establish a bidirectional crosstalk with MRCs
(a) IFA of spleens stained for MAdCAM-1 (green or red), IgD (blue), vWF (red) and/or 
RORγt (green). Original magnification, ×40 (upper panels), ×10 (upper inset) and ×63 
(bottom-left panel) and zoom ×2 (bottom-right panel). (b) Flow cytometry of PECAM-1, 
CD34, CD45, Thy-1, CD141, ICAM-1, VCAM-1, TLR3, TLR4 and TLR9 expression by ex 
vivo expanded MRCs. Gray shading, negative control. (c) qRT-PCR of IL1B (IL-1β), IL7 
(IL-7), IL23 (IL-23), CCL20 (CCL20), ICAM1 (ICAM-1) and MADCAM1 (MadCAM-1) 
mRNAs in MadCAM-1+ MRC-enriched (red box), MR+ SLC-enriched (blue box) and 
control (ctrl) MR– (black box) areas microdissected from immunohistochemically stained 
splenic tissue (original magnification, ×20). qRT-PCR results are normalized to ACTB (β-
actin) mRNA and presented as relative expression (RE) compared with that of MR– areas. 
(d) Flow cytometry of integrins α4 and β7 on freshly isolated splenic ILCs (left) or ILCs 
cultured with IL-1β and IL-7 for 72 h (right). (e,f) Flow cytometry of ICAM-1 and VCAM-1 
on MRCs incubated for 72 h with or without ILCs in the presence or absence of control 
(Ctrl), anti-TNF, anti-LTαβ or anti-TNF plus anti-LTαβ antibodies. (g,h) Flow cytometric 
analysis of frequency of Annexin-V–propidium iodide– ILCs from splenic ILCs cultured for 
72 h with or without MRCs in the presence of absence of a transwell, a control (Ctrl) 
antibody or anti-IL-7. Error bars, s.e.m.; *P <0.05 (two-tailed unpaired Student's t test). Data 
summarize three experiments with one donor in each (c,h) or show one of four experiments 
with similar results (a,b,d,e,f,g).
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Figure 3. Human splenic ILCs express the MZ B cell-helper factors BAFF, CD40L and DLL1 
and activate MZ B cells in cooperation with MRCs
(a) IHC of spleen stained for RORγt (brown) and CD20 (purple). Arrowheads point to 
RORγt+ cells. Original magnification, ×40. (b) qRT-PCR of TNFSF13B (BAFF), TNFSF13 
(APRIL), CD40LG (CD40L) and DLL1 (DLL1) mRNAs from splenic or tonsillar ILCs and 
NK cells and from splenic macrophages (Mϕ), B cells and T cells. Results are normalized to 
ACTB (β-actin) mRNA and presented as relative expression (RE) compared with that of 
fresh splenic NK cells. (c) Flow cytometry of BAFF, APRIL, CD40L and DLL1 on splenic 
ILCs exposed to IL-1β plus IL-7 for 72 h. Gray shading, negative control. (d) ELISA of 
soluble BAFF and APRIL from splenic ILCs and NK cells cultured as in (c) as well as Mϕ. 
(e) Flow cytometric analysis of the frequency of viable Annexin-V–propidium iodide (PI)– 
and divided carboxyfluorescein diacetate succinimidyl ester (CFSE)low splenic MZ (blue 
bars) and FO (pink bars) B cells after incubation with medium alone (ctrl) or ILCs for 5 d. 
(f) ELISA of IgM, IgG and IgA from splenic MZ B cells incubated for 5 d with medium 
alone (Ctrl), ILCs, MRCs and/or CpG. (g) Frequency of CD27hiCD38hi plasmablasts in 
splenic MZ B cells cultured for 5 d as in (f). Error bars, s.e.m.; *P <0.05 (two-tailed 
unpaired Student's t test). Data summarize 3 measurements from 3 pooled experiments with 
one donor in each (b,d) or show one of three experiments with similar results (a,c,e,f with 
s.e.m of triplicate, g).
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Figure 4. Human splenic ILCs help MZ B cells via BAFF, CD40L and DLL1
(a,b) Flow cytometric analysis of the frequency of viable DAPI– MZ B cells from MZ B 
cells cultured for 5 d with or without splenic ILCs in the presence or absence of control Ig or 
BAFF-R-Ig. SSC-A, side scatter area. (b) Frequency of CD27hiCD38hi plasmablasts from 
splenic MZ B cells cultured for 5 d with or without splenic ILCs or ILC conditioned 
medium (ILC-CM). (c) ELISA of IgM from splenic MZ B cells cultured as in (b). (d) 
ELISA of IgM from splenic MZ B cells cultured for 5 days with medium alone (Ctrl) or 
ILCs in the presence or absence of control Ig and dimethyl sulfoxide vehicle (Vehi), BAFF-
R-Ig, CD40-Ig, N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester 
(DAPT, a NOTCH inhibitor) or a combination of BAFF-R-Ig plus CD40-R-Ig plus DAPT 
(All). Summary of data from 7 donors shown as % of maximal induction (100%) after MZ B 
cell stimulation with ILCs and control vehicle (Vehi). (e) Frequency of CD27hiCD38hi 
plasmablasts from splenic MZ B cells cultured for 5 days with control OP9 cells or DLL1-
OP9 cells in the presence or absence of BAFF. (f) Frequency of CD27hiCD38hi plasmablasts 
from splenic MZ B cells cultured for 5 d with or without control (ctrl) OP9 cells or DLL1-
OP9 cells in the presence or absence of BAFF and/or DAPT. (g) ELISA of IgM from splenic 
MZ B cells cultured as in (e). Error bars, s.e.m.; *P <0.05 (two-tailed unpaired Student's t 
test). Data summarize four (a), three (b,c,e) and seven (d) experiments with one donor in 
each or show one of three experiments with similar results (f, g with s.e.m of triplicate).
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Figure 5. Human splenic ILCs activate MZ B cell-helper neutrophils via GM-CSF
(a) IHC of spleen stained for CD117 (red) and CD66 (brown). Original magnification, ×20 
or ×40 (inset). (b) Left: qRT-PCR of CSF2 (GM-CSF) and IL8 (IL-8) mRNAs from splenic 
ILCs, NK cells, macrophages (Mϕ), B cells and T cells. CSF2 and IL8 data are normalized 
to ACTB (β-actin) mRNA and presented as relative expression (RE) compared with that of 
fresh splenic NK cells. Right: ELISA of GM-CSF and IL-8 from splenic ILCs and NK cells 
cultured for 48 h with IL-1β and IL-7. (c) Flow cytometry of intracellular GMCSF and IL-8 
in splenic CD127+ (Lin–CD117+) ILCs activated with or without PMA (P) plus ionomycin 
(I) for 4 h. (d) Flow cytometry of CD69, CD11b, CD24 and CD62L on Nc cells cultured for 
24 h with or without splenic ILCs in the presence or absence of control IgG1 or blocking 
anti-GM-CSF antibodies. Gray shading: isotype control. (e) Flow cytometry of viable 
DAPI– Nc cells cultured with medium alone (Ctrl), GM-CSF, ILCs or ILC-derived 
conditioned medium (ILC-CM) in the presence or absence of IgG1 or anti-GM-CSF 
antibodies. (f) qRT-PCR of TNFSF13 (APRIL) mRNA from Nc cells cultured for 24 h with 
medium alone (Ctrl), GM-CSF or ILC-CM. Results are normalized to ACTB mRNA and 
presented as RE compared with that of Nc cells cultured with medium alone. (g) ELISA of 
IgA from splenic MZ B cells cultured for 5 d with or without Nc cells, ILCs and/or ILC-CM. 
(h) ELISA of IgM, IgA and IgG from splenic MZ B cells cultured for 5 d with or without 
NBH cells, ILC-CM and/or NBH cells preconditioned with ILC-CM. (i) IFA of elastase 
(green) and DAPI-stained DNA (blue) in Nc cells cultured for 3 h either with medium alone 
(Ctrl), GM-CSF, ILC-CM or LPS (original magnification, ×63) and quantification of NET-
forming Nc cells from nine ×10 fields from two independent experiments. Error bars, s.e.m.; 
*P <0.05 (two-tailed unpaired Student's t test). Data summarize 2-3 experiments with one 
donor in each (b,e,f,g,h,i) or show one of four experiments with similar results (a,c,d).
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Figure 6. Mouse splenic ILCs express the plasma cell-helper factors APRIL and DLL1 and 
enhance TI IgG3 responses
(a) Flow cytometric analysis of frequency and absolute numbers of splenic Lin– 
CD117+CD127+ ILCs from Rorc+/+ (n = 3) and Rorc–/– mice (n = 3). (b) qRT-PCR of Rorc 
(RORγt) Il22 (IL-22) Tnf (TNF), Lta (LT-α), Tnfsf13 (APRIL), Tnfsf13b (BAFF), CD40lg 
(CD40L) and Dll1 (DLL1) mRNAs from splenic ILCs, macrophages (Mϕ), DCs, 
neutrophils, NK cells, T cells or B cells. Results are normalized to Gapdh (glyceraldehyde 
3-phosphate dehydrogenase) mRNA and presented as relative expression (RE) compared to 
the expression level in NK cells. (c) Flow cytometric analysis of frequency and absolute 
numbers of splenic IgG3E+IgG3Ilo B cells, IgG3EhiIgG3I+ plasmablasts (PBs) and 
IgG3E+IgG3Ihi plasma cells (PCs) from Rorc+/+ (n = 3) and Rorc–/– mice. E, extracellular; I, 
intracellular. (d) IFA of IgM (green), IgG3 (red) and MOMA-1 (blue) in spleens from 
Rorc+/+ and Rorc–/– mice. Original magnification, ×20. (e,f) ELISA of total (e) and PC-
reactive (f) serum IgG3 from Rorc+/+ (n = 6-7) and Rorc–/– (n = 7-8) mice. (g) Frequency of 
IgG3-expressing B cells, PBs and PCs from spleens of Rorc+/–Cd3e–/– and Rorc–/–Cd3e–/– 
mice. (h) Serum IgG3 from Rorc+/–Cd3e–/– (n = 9) and Rorc–/–Cd3e–/– (n = 6) mice. Error 
bars, s.e.m. (b), s.d. (a,c); *P <0.05 (one-tailed unpaired Student's t test). Data show one of 
four experiments with similar results (a,d,g; c: cytograms) or summarize results from 3-8 
animals per each group (a,c: bars; b,e,f,h).
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Figure 7. Mouse splenic ILCs help plasmablasts and plasma cells emerging from TI IgG3 
responses
(a) Flow cytometric analysis of frequency and absolute numbers of splenic 
Lin–CD117+CD127+ ILCs from Thy-1-disparate chimeric Rag1–/– mice treated with control 
(ctrl) (n = 7) or anti-Thy.1.2 antibodies (n = 7). (b) Frequency and absolute numbers of 
splenic IgG3E+IgG3Ilo B cells, IgG3EhiIgG3I+ plasmablasts (PBs) and IgG3E–IgG3Ihi 
plasma cells (PCs) from Ctrl or ILC-depleted mice obtained as in (a). E, extracellular; I, 
intracellular. (c,d) ELISA of pre-immune total (c) and PC-reactive (d) serum IgG3 from Ctrl 
or ILC-depleted mice obtained as in (a). (e,f) Frequency and absolute numbers of splenic 
Lin– CD117+CD127+ ILCs (e) and IgG3-expressing splenic B cells, PBs and PCs (f) from 
ILC+ (n = 3) or ILC– (n = 3) bone marrow chimeric mice. (g) Pre-immune total serum IgG3 
from ILC+ (n = 4) and ILC– (n = 3) mice, age-matched Rorc+/+ mice (n = 10), and Rorc–/– 
mice (n = 5). Error bars, s.d.; *P <0.05 (one-tailed unpaired Student's t test). Data show one 
of four experiments with similar results (a,b,e,f: cytograms) or summarize results from 3-10 
animals per each group (a,b,e,f: bars; c,d,g).
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Figure 8. Mouse splenic neutrophils help plasma cells emerging from TI IgG3 responses and 
receive homeostatic signals from ILCs via GM-CSF
(a) IFA of IgG3 (green), Ly6G (red) and IgM (blue) in spleens from ILC+ or ILC– bone 
marrow chimeric mice. Original magnification, ×20. (b) Flow cytometric analysis of the 
frequency of splenic Ly6G+CD11b+ neutrophils from ILC+ (n = 3) or ILC– (n = 3) mice. (c) 
Frequency and absolute numbers of splenic Ly6G+CD11b+ neutrophils from ILC+ mice 
treated with control (Ctrl) (n = 4) or anti-Ly6G antibodies (n = 4). (d,e) Frequency and 
absolute numbers of splenic Lin–CD117+CD127+ (d) as well as splenic IgG3E+IgG3Ilo B 
cells, IgG3EhiIgG3I+ plasmablasts (PBs) and IgG3E+IgG3Ihi plasma cells (PCs) from ILC+ 
mice treated as in (c). E, extracellular; I, intracellular. (f) ELISA of total serum IgG3 from 
ILC+ mice treated as in (c). (g) qRT-PCR of Csf2 (GM-CSF) mRNA from splenic ILCs, 
macrophages (Mϕ), DCs, neutrophils, NK cells, T cells or B cells. Results are normalized to 
Gapdh (glyceraldehyde 3-phosphate dehydrogenase) mRNA and presented as relative 
expression (RE) compared to the expression level in NK cells. (h) Frequency and absolute 
numbers of splenic Ly6G+CD11b+ neutrophils from Csf2+/+ (n = 8) and Cfs2–/– (n = 12) 
mice before and after transfer of B16Cfs2 cells overexpressing GM-CSF (n = 3). (i) 
Frequency of splenic neutrophils in ILC-sufficient Rag1–/–Il2rg+/+ mice or ILC-insufficient 
Rag1–/–Il2rg–/– mice reconstituted or not with gut ILCs from Csf2+/+ or Cfs2–/– mice (n = 3). 
Error bars, s.e.m. (g-i), s.d. (b-e); *P <0.05 (one-tailed unpaired Student's t test). Data 
summarize results from at least two experiments with 3 mice in each group (b,c,d,e,h: bars; 
f,g,i) or show one of at least three experiments with similar results (a and b,c,d,e,h: 
cytograms).
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